Navigation Links
Targeted therapy extends progression-free survival of patients with advanced ovarian cancer
Date:12/28/2011

PHILADELPHIA, PA (December 28, 2011)Targeted drugs, which block or disrupt particular molecules involved in the growth of tumors, have been shown to be effective treatments against many types of cancer. A new phase 3 clinical trial conducted by the Gynecologic Oncology Group (GOG) showed that a targeted therapy called bevacizumab (Avastin) effectively delayed the progression of advanced ovarian cancer. Patients with newly diagnosed advanced ovarian cancer now typically undergo surgery and chemotherapy, but the new research suggests an additional avenue of treatment. The results of the trial appear in the December 29 issue of the New England Journal of Medicine.

"This approach can be looked upon as a third major component of treatment for ovarian cancer and related malignancies," says Robert A. Burger, MD, lead investigator on the GOG study and director of the Women's Cancer Center at Fox Chase Cancer Center. "We've had the combination of surgical management and cytotoxic chemotherapy for many years, but we haven't really seen anything else in terms of a fundamental class of treatment. This represents a new way for us to control the disease."

The placebo-controlled study, which was sponsored by the National Cancer Institute, enrolled 1,873 patients with previously untreated advanced disease from 336 sites, primarily in the United States, but also in Canada, South Korea, and Japan. The patients either had stage III ovarian cancer that could not be entirely removed with surgery, or stage IV disease, and were randomly assigned to one of three groups. For patients who received bevacizumab with chemotherapy followed by bevacizumab for up to an additional 10 months, the median time until their cancer progressed was 14.1 months, compared to 10.3 months for patients in the control group, who received chemotherapy with a placebo and then continued with a placebo. The net effect was a 28% reduction in the risk of disease of ovarian cancer p
'/>"/>

Contact: Diana Quattrone
Diana.Quattrone@fccc.edu
215-728-7784
Fox Chase Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Targeted delivery of losartan reduces liver inflammation and scarring
2. Gene-Targeted Cancer Fix Could Be a Breakthrough
3. Survival in metastatic breast cancer patients is improving: targeted therapies have contributed
4. Targeted agent blocked growth of deadly brain cancer in preclinical studies
5. Kaiser Permanente Southern California to Offer FitOrbit Online Personal Training to Targeted Patients
6. New targeted therapy effective in treating advanced prostate cancer
7. Gene-Targeted Therapy Might Help Prevent Paralysis
8. Site Steering Launches Keyword Targeted Small Business Internet Video Advertising Program That Achieves First Page Search Results Within Days
9. Drug in new class of targeted therapies shows early promise against blood-related cancers
10. Women Smokers Targeted on World No Tobacco Day
11. Targeted immunotherapy shows promise for metastatic breast, pancreatic cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... Ultraman Florida is a grueling extreme athletic ... bike, and 52.4 mile run. Christian Isakson finished in ... "This race was awesome and tough," Isakson said. "I ... for supporting me through every part of this brutal ... of 40 select participants invited from across the United ...
(Date:3/4/2015)... March 04, 2015 TROY Healthcare Solutions ... which provides the ultimate level of security for prescriptions, ... Hilton Houston Plaza Medical Center located at 6633 Travis ... Beginning at 7 AM, TROY Healthcare Solutions will host ... Solutions will offer brief presentations each hour to introduce ...
(Date:3/4/2015)... Smokers across America are the target ... Love Smokers' from Aqua-Tine, the new brand that helps ... important to establish a clear point of view for ... 'We Love Smokers' elevates the Aqua-Tine brand, gives it ... a bold tone of voice that is also genuinely ...
(Date:3/4/2015)... 04, 2015 Starting February 2015, Dr. ... PRK procedures at their new location in Surrey. , ... King and Dr. Gabriel Chu also provide comprehensive ophthalmology ... is named Fraser Valley Cataract and Laser (FVCL). This ... the College of Physicians and Surgeons of British Columbia. ...
(Date:3/4/2015)... " Optrix by Body Glove ” was ... Report, which takes a look at the latest and ... Steinberg, a special reporter for NewsWatch and a technology ... how they have an ultra-rugged, waterproof case with an ... major player at the Consumer Electronics Show in Las ...
Breaking Medicine News(10 mins):Health News:Living Fuel Champion Christian Isakson Finishes Second In UltraMan Florida Test of Endurance 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 3Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 2Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 3Health News:King LASIK relocates to Surrey, British Columbia 2Health News:A Waterproof Phone Case with an Interchangeable Lens System was Featured on NewsWatch Television on January 30, 2015 2
... Minn. -- The Medical Publishing Insights and Practices ... journal editors to characterize the persistent and perceived ... identify potential approaches to resolve it. This unique ... Ten Recommendations for Closing the Credibility Gap in ...
... By Randy Dotinga HealthDay Reporter , MONDAY, May ... front of the TV have poorer diets overall, a new study ... that TV watching has anything to do with what kids eat, ... more important than time spent with "American Idol" or "SpongeBob SquarePants." ...
... -- Giving earplugs to patients in the intensive care unit ... onset of delirium, according to a new study. It ... delirium in ICU patients, and research has shown that ICU ... in the ICU from equipment and people coming and going. ...
... hard to diagnose as well as treat, but researchers at ... discovered a way of confirming the disorder using stool samples. ... with pain and discomfort in the abdomen together with changes ... to be linked to dysfunction of the stomach and intestines, ...
... risk of prostate cancer can be beneficial in reducing ... states an article published in CMAJ ( ... Preventive Services Task Force, which last issued prostate screening ... prostate-specific antigen (PSA) screening for men of all ages. ...
... Professor Keon Jae Lee ( http://fand.kaist.ac.kr/ ) from ... has developed new forms of low cost, large-area ... Piezoelectric effects-based nanogenerator technology that converts existing sources ... energy from the nature of wind and waves, ...
Cached Medicine News:Health News:Journals and pharma collaborate on new recommendations 2Health News:Lots of TV May Harm Kids' Diet 2Health News:Lots of TV May Harm Kids' Diet 3Health News:Using Earplugs Eases ICU Patients' Confusion: Study 2Health News:PSA screening to detect prostate cancer can be beneficial to younger and at-risk men 2
(Date:3/4/2015)... 4, 2015  Bayer HealthCare today announced that ... accepted the company,s Biologics License Application (BLA) for ... is seeking FDA approval of the investigational compound, ... hemophilia A in children and adults. ... therapies to hemophilia A patients who need them," ...
(Date:3/4/2015)... , March 4, 2015  Students from Indiana University ... how new medicines are discovered. Through a partnership with ... medical students from IU School of Medicine are learning ... at Lilly play different and important roles in bringing ... a former medical educator, scientific investigator, and health system ...
(Date:3/4/2015)... 4, 2015   InspireMD, Inc.  ("InspireMD" or the ... systems ("EPS"), today announced that it has entered into ... million shares of common stock and warrants to purchase ... in a public offering.  The common stock will be ... share, and each purchaser will receive a warrant to ...
Breaking Medicine Technology:FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 3Lilly and IU School of Medicine Partner on Rotation Program for Medical Students 2Lilly and IU School of Medicine Partner on Rotation Program for Medical Students 3InspireMD Announces Public Offering for Approximately $13.5 Million 2InspireMD Announces Public Offering for Approximately $13.5 Million 3InspireMD Announces Public Offering for Approximately $13.5 Million 4
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 11 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 6.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 10.0 mm and length 12 mm....
Medicine Products: